Anti-cold medication :: Consumers survey results of for 3 quarter of 2017

Consumers survey results of for 3 quarter of 2017 in category

Cold and Flu / Anti-cold medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	2	Афлубін (Perrigo)	31.58%	5

2.	4	Amizon (Farmak)	26.32%	4.17

3.	4	Терафлю (Novartis OTC)	21.05%	3.33

4.	6	Antiflu (Bayer)	15.79%	2.50

4.	5	Інсті (Herbion)	15.79%	2.50

4.		Маліпін (Vishpha \| Фармацевтична фабрика Vishpha)	15.79%	2.50

4.	~	Розтиран (Vishpha \| Фармацевтична фабрика Vishpha)	15.79%	2.50

4.	6	Фармацитрон (Pharmascience)	15.79%	2.50

4.	2	Фервекс (Bristol-Myers Squibb)	15.79%	2.50

10.	6	IRS 19 (Abbott Laboratories)	10.53%	1.67

10.	~	Анаферон (Materia Medica – Ukraine)	10.53%	1.67

10.	6	Антигрипін (Національна гомеопатична спілка)	10.53%	1.67

10.	4	Грип-Хеель (Heel)	10.53%	1.67

10.	6	Грипомед (Red star)	10.53%	1.67

10.	3	Колдрекс (GlaxoSmithKline)	10.53%	1.67

10.	1	Мілістан (Mili Healthcare)	10.53%	1.67

17.		Хелпекс (Movi Health GmbH)	5.26%	0.83

17.	~	Arbidol (OTC-Фарм)	5.26%	0.83

17.	5	Ergoferon (Materia Medica – Ukraine)	5.26%	0.83

17.	5	Грипмакс (Unipharm, Inc)	5.26%	0.83

17.	~	Колдрін (Teva)	5.26%	0.83

17.	6	Комбігрип (ORGANOSYN)	5.26%	0.83

17.	6	Ринза (Johnson & Johnson)	5.26%	0.83

–.	5	Gripex (Delta Medical)	0.00%	0

–.	6	Rinicold (Shreya Life Sciences)	0.00%	0

–.		Вікс Актив (Dr. Reddy’s)	0.00%	0

–.	5	Гриппостад (Nizhpharm)	0.00%	0

–.		Грипфлю (Ananta Medicare Ltd.)	0.00%	0

–.	5	Колдфлю Екстра (Genom Biotech)	0.00%	0

–.		Лекадол плюс C (Sandoz)	0.00%	0

–.	4	Флюколд-N (Nabros Pharma)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2017, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.